CAS 22105-10-8

3-Hydroxy-2-methyl-4H-chromen-4-one

CAS: 22105-10-8

3-Hydroxy-2-methyl-4H-chromen-4-one is a synthetic compound that has been shown to have potential use as an anticancer agent. It was originally developed for the treatment of cancer, but clinical studies have been limited due to its poor solubility and toxicity. 3-Hydroxy-2-methyl-4H-chromen-4-one has antiangiogenic effects, which means it prevents the formation of new blood vessels that are necessary for tumor growth. This effect may be due to its ability to inhibit the production of substances that stimulate angiogenesis, such as erythropoietin and vascular endothelial growth factor (VEGF). In addition, 3HMMCT inhibits iron homeostasis by binding to ferric iron in the enterocyte lysosome and preventing its absorption from food. This leads to increased excretion of iron in feces and urine.

Formula: C₁₀H₈O₃

Purity: Min. 95%

Molecular weight: 176.17 g/mol

Ref: 3D-XAA10510